278 related articles for article (PubMed ID: 28505294)
1. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.
Park CS; Kim YJ; Lee JR; Lim HG; Chang JE; Jeong S; Kwon N
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):391-399. PubMed ID: 28505294
[TBL] [Abstract][Full Text] [Related]
2. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
3. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
4. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice.
Lim HG; Choi SY; Jeong S; Shin JS; Park CG; Kim YJ
J Biomater Appl; 2015 Feb; 29(7):929-40. PubMed ID: 25245780
[TBL] [Abstract][Full Text] [Related]
6. Development of novel combined anticalcification protocols including immunologic modification for prolonged durability of cardiac xenograft: preclinical study using large-animal long-term circulatory models.
Lim HG; Jeong S; Shin JS; Park CG; Kim YJ
ASAIO J; 2015; 61(1):87-95. PubMed ID: 25303800
[TBL] [Abstract][Full Text] [Related]
7. A novel tissue treatment to reduce mineralization of bovine pericardial heart valves.
Meuris B; De Praetere H; Strasly M; Trabucco P; Lai JC; Verbrugghe P; Herijgers P
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):197-206. PubMed ID: 29572021
[TBL] [Abstract][Full Text] [Related]
8. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts.
Lee C; Ahn H; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697
[TBL] [Abstract][Full Text] [Related]
9. High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect.
Lee C; Kim SH; Choi SH; Kim YJ
Eur J Cardiothorac Surg; 2011 Mar; 39(3):381-7. PubMed ID: 20739186
[TBL] [Abstract][Full Text] [Related]
10. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
11. Effects of glutaraldehyde concentration and fixation time on material characteristics and calcification of bovine pericardium: implications for the optimal method of fixation of autologous pericardium used for cardiovascular surgery.
Lee C; Lim HG; Lee CH; Kim YJ
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):402-406. PubMed ID: 28011740
[TBL] [Abstract][Full Text] [Related]
12. Effect of SDS-based decelullarization in the prevention of calcification in glutaraldehyde-preserved bovine pericardium: study in rats.
Collatusso C; Roderjan JG; Vieira ED; Costa FD; Noronha Ld; Fornazari Dde F
Rev Bras Cir Cardiovasc; 2012; 27(1):88-96. PubMed ID: 22729305
[TBL] [Abstract][Full Text] [Related]
13. Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
Lim HG; Kim GB; Jeong S; Kim YJ
Eur J Cardiothorac Surg; 2015 Jul; 48(1):104-13. PubMed ID: 25315752
[TBL] [Abstract][Full Text] [Related]
14. Decellularization as an anticalcification method in stentless bovine pericardium valve prosthesis: a study in sheep.
Collatusso C; Roderjan JG; Vieira ED; Myague NI; Noronha Ld; Costa FD
Rev Bras Cir Cardiovasc; 2011; 26(3):419-26. PubMed ID: 22086579
[TBL] [Abstract][Full Text] [Related]
15. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
Bianco RW; Phillips R; Mrachek J; Witson J
J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
[TBL] [Abstract][Full Text] [Related]
16. Valved conduit with glutaraldehyde-fixed bovine pericardium treated by anticalcification protocol.
Lim HG; Kim GB; Jeong S; Kim YJ
Korean J Thorac Cardiovasc Surg; 2014 Aug; 47(4):333-43. PubMed ID: 25207241
[TBL] [Abstract][Full Text] [Related]
17. In search of the best xenogeneic material for a paediatric conduit: an analysis of clinical data.
Nichay NR; Zhuravleva IY; Kulyabin YY; Timchenko TP; Voitov AV; Kuznetsova EV; Soynov IA; Zubritskiy AV; Bogachev-Prokophiev AV; Karaskov AM
Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):34-41. PubMed ID: 29452369
[TBL] [Abstract][Full Text] [Related]
18. New-generation valved conduit: an experimental study.
Chanda J; Kuribayashi R; Abe T
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):218-23. PubMed ID: 9270639
[TBL] [Abstract][Full Text] [Related]
19. Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments.
van Steenberghe M; Schubert T; Gerelli S; Bouzin C; Guiot Y; Xhema D; Bollen X; Abdelhamid K; Gianello P
J Cardiothorac Surg; 2018 Apr; 13(1):34. PubMed ID: 29695259
[TBL] [Abstract][Full Text] [Related]
20. Kangaroo vs. porcine aortic valves: calcification potential after glutaraldehyde fixation.
Narine K; Chéry CC; Goetghebeur E; Forsyth R; Claeys E; Cornelissen M; Moens L; Van Nooten G
Eur Surg Res; 2005; 37(3):137-43. PubMed ID: 16088178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
